F. Geoffroy

发表

Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells.

J. Grem, D. Nguyen, B. Monahan, 1999, Biochemical pharmacology.

Relative frequencies and sites of presentation of lymphoid neoplasms in a community hospital according to the revised European-American classification.

F. Geoffroy, P. Fishkin, J. D. Siebert, 1999, American journal of clinical pathology.

Phase I trial of erlotinib with radiation therapy (RT) in patients with glioblastoma multiforme (GBM)

J. Uhm, J. Buckner, P. Brown, 2005 .

Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.

S. Steinberg, J. Grem, C. Allegra, 1995, Molecular pharmacology.

Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.

P. Johnston, J. Grem, C. Allegra, 1997, Oncology research.

Enhanced cytotoxicity with interleukin-1α and 5-fluorouracil in HCT116 colon cancer cells

J. Grem, C. Allegra, F. Geoffroy, 1994 .

Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer.

E. Perez, S. Hillman, R. Marks, 2004, Lung cancer.

Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.

J. Grem, C. Allegra, F. Geoffroy, 1994, Oncology research.

Isolated CNS Hodgkin's lymphoma: implications for tissue diagnosis.

M. Gujrati, A. Tsung, F. Geoffroy, 2014, CNS oncology.

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2022, JAMA oncology.

Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma.

J. Grem, C. Allegra, G. Aherne, 1998, Molecular pharmacology.

Cytotoxicity and metabolism of 4-methoxy-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine in HCT 116 colon cancer cells.

J. Grem, C. Allegra, J. Trepel, 1994, Biochemical pharmacology.

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.

Caterina Giannini, Howard Gross, Chunrong Yu, 2012, Neuro-oncology.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2018, Journal of Translational Medicine.

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.

Caterina Giannini, Jan C Buckner, Paul D Brown, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.

J. Uhm, J. Buckner, P. Brown, 2006, International journal of radiation oncology, biology, physics.

Determinants of trimetrexate lethality in human colon cancer cells.

P. Johnston, J. Grem, C. Allegra, 1994, British Journal of Cancer.

Modulation of Fluorouracil Cytotoxicity by Interferon- a and - g

J. Grem, C. Allegra, G. Aherne, 1998 .

Effects of 9-aminocamptothecin on newly synthesized DNA in patient bone marrow samples.

C. Takimoto, J. Grem, W. Dahut, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

A randomized phase 2 study of temozolomide and bevacizumab or nab‐paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma

R. McWilliams, V. Suman, S. Markovic, 2013, Cancer.

Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.

R. Arusell, J. Jett, S. Hillman, 2004, International journal of radiation oncology, biology, physics.

Topotecan and Paclitaxel in Previously Treated Patients with Relapsed Small Cell Lung Cancer: Phase II Trial of the North Central Cancer Treatment Group

J. Jett, J. Krook, J. Kugler, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2018, Journal of Translational Medicine.

Phase Ii Trial of Vorinostat in Combination with Bortezomib in Recurrent Glioblastoma: a North Central Cancer Treatment Group Study Neuro-onco Lo Gy

E. Galanis, K. Jaeckle, E. Pajon, 2022 .